| Pharmaceutical active ingredients: |
| Chloroquine |
| Available forms, composition and doses of Siragan: |
| N / A |
| Siragan medical category: |
| Human:AntiamoebicsAntimalarialsDisease-modifying anti-rheumatic drugs (DMARDs)Eye anti-infectives and antiseptics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| P01BA01 - Chloroquine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Sipon | Sodium Lauryl Sulfate | Unidentified Pharmaceutical Company |
| Siponic L | Laureth-9 | Unidentified Pharmaceutical Company |
| Siponol | Cetyl Alcohol | Unidentified Pharmaceutical Company |
| Siptazin | Cinnarizine | Unidentified Pharmaceutical Company |
| Siptox I | Malathion | Unidentified Pharmaceutical Company |
| Siraliden | Nitrofurantoin | Unidentified Pharmaceutical Company |
| Sirbiocina | Novobiocin | Unidentified Pharmaceutical Company |
| Sirledi | Nimorazole | Unidentified Pharmaceutical Company |
| Sirlene | Propylene Glycol | Unidentified Pharmaceutical Company |
| Sirokal | Potassium Gluconate | Unidentified Pharmaceutical Company |